Lonza Forecast, price target & analysts
Lonza Target price 2025 - Analyst rating & recommendation
Lonza Classifications & Recommendation:
Lonza Price Target
| Target Price | CHF668.50 |
| Price | CHF542.20 |
| Potential | 23.29% |
| Number of Estimates | 22 |
| 22 Analysts have issued a price target Lonza 2026 . The average Lonza target price is CHF668.50. This is 23.29% higher than the current stock price. The highest price target is CHF744.00 37.22% , the lowest is CHF600.00 10.66% . | |
| A rating was issued by 26 analysts: 21 Analysts recommend Lonza to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Lonza stock has an average upside potential 2026 of 23.29% . Most analysts recommend the Lonza stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 6.57 | 7.72 |
| 2.13% | 17.37% | |
| EBITDA Margin | 26.36% | 28.66% |
| 20.05% | 8.72% |
23 Analysts have issued a sales forecast Lonza 2025 . The average Lonza sales estimate is CHF7.7b . This is 17.37% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.0b 21.05% , the lowest is CHF7.4b 12.90% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | CHF6.6b | 2.13% |
|---|---|---|
| 2025 | CHF7.7b | 17.37% |
| 2026 | CHF8.6b | 10.92% |
| 2027 | CHF9.6b | 11.95% |
| 2028 | CHF11.1b | 16.00% |
| 2029 | CHF12.6b | 13.04% |
22 Analysts have issued an Lonza EBITDA forecast 2025. The average Lonza EBITDA estimate is CHF2.2b . This is 48.40% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is CHF2.3b 55.91% , the lowest is CHF1.9b 28.30% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | CHF1.7b | 17.49% |
|---|---|---|
| 2025 | CHF2.2b | 27.59% |
| 2026 | CHF2.6b | 16.14% |
| 2027 | CHF3.0b | 15.00% |
| 2028 | CHF3.4b | 15.52% |
| 2029 | CHF4.1b | 21.59% |
EBITDA Margin
| 2024 | 26.36% | 20.05% |
|---|---|---|
| 2025 | 28.66% | 8.72% |
| 2026 | 30.00% | 4.68% |
| 2027 | 30.82% | 2.73% |
| 2028 | 30.69% | 0.42% |
| 2029 | 33.02% | 7.59% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 8.93 | 14.68 |
| 0.56% | 64.39% | |
| P/E | 38.19 | |
| EV/Sales | 5.51 |
20 Analysts have issued a Lonza forecast for earnings per share. The average Lonza EPS is CHF14.68 . This is 64.39% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF16.20 81.41% , the lowest is CHF12.99 45.46% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | CHF8.93 | 0.56% |
|---|---|---|
| 2025 | CHF14.68 | 64.39% |
| 2026 | CHF17.96 | 22.34% |
| 2027 | CHF21.66 | 20.60% |
| 2028 | CHF27.23 | 25.72% |
| 2029 | CHF35.56 | 30.59% |
P/E ratio
| Current | 62.78 | 5.23% |
|---|---|---|
| 2025 | 38.19 | 39.17% |
| 2026 | 31.21 | 18.28% |
| 2027 | 25.88 | 17.08% |
| 2028 | 20.59 | 20.44% |
| 2029 | 15.76 | 23.46% |
Based on analysts' sales estimates for 2025, the Lonza stock is valued at an EV/Sales of 5.51 and an P/S ratio of 5.11 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 6.46 | 6.95% |
|---|---|---|
| 2025 | 5.51 | 14.78% |
| 2026 | 4.96 | 9.84% |
| 2027 | 4.43 | 10.67% |
| 2028 | 3.82 | 13.79% |
| 2029 | 3.38 | 11.54% |
P/S ratio
| Current | 6.00 | 2.35% |
|---|---|---|
| 2025 | 5.11 | 14.80% |
| 2026 | 4.61 | 9.84% |
| 2027 | 4.11 | 10.67% |
| 2028 | 3.55 | 13.79% |
| 2029 | 3.14 | 11.54% |
Current Lonza Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| KEYBANC CAPITAL MARKETS INC. |
Overweight
➜
Overweight
|
Unchanged | Jan 05 2025 |
| BERENBERG |
Buy
➜
Buy
|
Unchanged | Jan 02 2025 |
| RESEARCH PARTNERS AG |
Buy
➜
Buy
|
Unchanged | Dec 15 2024 |
| EQUITA SIM |
Buy
➜
Hold
|
Downgrade | Dec 12 2024 |
| ODDO BHF |
Buy
➜
Buy
|
Unchanged | Dec 11 2024 |
| STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Dec 11 2024 |
| WILLIAM BLAIR & COMPANY |
Outperform
➜
Outperform
|
Unchanged | Dec 11 2024 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
KEYBANC CAPITAL MARKETS INC.:
Overweight
➜
Overweight
|
Jan 05 2025 |
|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Jan 02 2025 |
|
Unchanged
RESEARCH PARTNERS AG:
Buy
➜
Buy
|
Dec 15 2024 |
|
Downgrade
EQUITA SIM:
Buy
➜
Hold
|
Dec 12 2024 |
|
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Dec 11 2024 |
|
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Dec 11 2024 |
|
Unchanged
WILLIAM BLAIR & COMPANY:
Outperform
➜
Outperform
|
Dec 11 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
